US Stock MarketDetailed Quotes

FDMT 4D Molecular Therapeutics

Watchlist
  • 26.470
  • -0.290-1.08%
Trading May 7 10:26 ET
1.35BMarket Cap-10259P/E (TTM)

4D Molecular Therapeutics Key Stats

4D Molecular Therapeutics Earnings Date

Currency: USD

Period

Q4 FY2023 Earnings

--

Revenue(YoY)

-19.00K

-101.52%
EPS(YoY)

-0.77

+8.33%

Strong Buy

May 7, 2024

4D Molecular Therapeutics Earnings Estimates

Revenue

EPS

EBIT

Revenue is based on 6 analyst forecasts. Estimate data is from S&P, and actual data is from Income Statement

Currency: USD

Actual
Estimate
DatePeriodRevenue/EstimateEarnings Call
--2024/Q2-- / 1.039M--
--2024/Q1-- / 1.068M--
--2023/Q4-19.000K / 2.400M--
--2023/Q320.204M / 9.219M--
--2023/Q2239.000K / 1.018M--
--2023/Q1298.000K / 1.285M--
--2022/Q41.247M / 3.757M--
--2022/Q3500.000K / 1.168M--
--2022/Q2162.000K / 1.141M--
--2022/Q11.219M / 758.330K--
DatePeriodRevenue/EstimateEarnings Call
--2024/Q2-- / 1.039M--
--2024/Q1-- / 1.068M--
--2023/Q4-19.000K / 2.400M--
--2023/Q320.204M / 9.219M--
--2023/Q2239.000K / 1.018M--
--2023/Q1298.000K / 1.285M--
--2022/Q41.247M / 3.757M--
--2022/Q3500.000K / 1.168M--
--2022/Q2162.000K / 1.141M--
--2022/Q11.219M / 758.330K--

Unlock Free Earnings Estimates

4D Molecular Therapeutics Earnings Reports

Read more

Analysis

Analyst Rating

Updated: May 7, 2024

Strong Buy

  • Buy

    100.00%
  • Hold

    0.00%
  • Sell

    0.00%

Price Target

No Data

Heat List
US
Overall
Symbol
Latest Price
%Chg